{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T18:00:49Z","timestamp":1792864849777,"version":"4.5.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jaut.2009.02.011","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T06:01:51Z","timestamp":1238133711000},"page":"178-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":240,"title":["Beh\u00e7et's disease \u2013 a contemporary review"],"prefix":"10.1016","volume":"32","author":[{"given":"Daniela","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Barbedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Vaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2009.02.011_bib1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002281-200401000-00008","article-title":"Beh\u00e7et's syndrome","volume":"16","author":"Yurdakul","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7ets disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/rheumatology\/kel382","article-title":"A cost analysis of Beh\u00e7et's syndrome in Turkey","volume":"46","author":"Sut","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjo.40.6.355","article-title":"Description of Beh\u00e7et's syndrome in the Hippocratic third book of endemic diseases","volume":"40","author":"Feigenbaum","year":"1956","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.euje.2006.12.007","article-title":"The migration pattern, patient selection with diagnostic methodological flaw and confusing naming dilemma in Beh\u00e7et disease","volume":"8","author":"Evereklioglu","year":"2007","journal-title":"Eur J\u00a0Echocardiogr"},{"key":"10.1016\/j.jaut.2009.02.011_bib7","first-page":"471","article-title":"Benediktos Adamantiades and his forgotten contributions to medicine","volume":"12","author":"Zouboulis","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib8","first-page":"1152","article-title":"\u00dcber rezidivierende, aphth\u00f6se, durch ein virus verursachte Geschw\u00fcre am Mund, am Auge und an den Genitalien","volume":"105","author":"Beh\u00e7et","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"10.1016\/j.jaut.2009.02.011_bib9","first-page":"420","article-title":"Considerations sur les lesions aphteuses de la bouche et des parties genitals, ainsi que sur les manifestations oculaires d'origine probablement virutique et observations concernant leur foyer d'infection","volume":"45","author":"Beh\u00e7et","year":"1938","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"10.1016\/j.jaut.2009.02.011_bib10","first-page":"1222","article-title":"Einige Bemerkungen zu meinen Beobachtungen \u00fcber den Tri-Symptomenkomplex","volume":"35","author":"Beh\u00e7et","year":"1939","journal-title":"Med Welt"},{"key":"10.1016\/j.jaut.2009.02.011_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000253787","article-title":"Some observations on the clinical picture of the so-called triple symptom complex","volume":"81","author":"Beh\u00e7et","year":"1940","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaut.2009.02.011_bib12","first-page":"51","article-title":"Prof. Dr. Hulusi Behcet (a famous Turkish physician) (1889\u20131948) and Behcet's disease from the point of view of the history of medicine and some results","volume":"5","author":"Erdemir","year":"2006","journal-title":"J Intl Soc Hist Islamic Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ard.62.7.691","article-title":"Early descriptions of Adamantiades-Beh\u00e7et's disease","volume":"62","author":"Zouboulis","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1378\/chest.119.2.667-a","article-title":"Some historical notes on Beh\u00e7et's disease","volume":"119","author":"Cheng","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2009.02.011_bib15","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1378\/chest.120.6.2116","article-title":"Some more historical notes on Adamantiades-Beh\u00e7et's disease","volume":"120","author":"Tirilomis","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2009.02.011_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Beh\u00e7et's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2009.02.011_bib17","first-page":"488","article-title":"Epidemiology of Adamantiades-Beh\u00e7et's disease","volume":"150","author":"Zouboulis","year":"1999","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.jaut.2009.02.011_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Beh\u00e7et's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaut.2009.02.011_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Behcet disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-4362.2003.01741.x","article-title":"Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease","volume":"42","author":"Tursen","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ard.22.1.36","article-title":"Clinical studies on Beh\u00e7et's syndrome","volume":"22","author":"Oshima","year":"1963","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Beh\u00e7et's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-3083.2007.02556.x","article-title":"Late-onset Beh\u00e7et's disease does not correlate with indolent clinical course: report of seven Taiwanese patients","volume":"22","author":"Tsai","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaut.2009.02.011_bib25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1365-4632.2006.02921.x","article-title":"Clinical features of late-onset Beh\u00e7et's disease: report of nine cases","volume":"45","author":"Saricaoglu","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/ard.59.8.622","article-title":"Familial aggregation of Beh\u00e7et's disease in Turkey","volume":"59","author":"G\u00fcl","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","article-title":"Clinical features of Beh\u00e7et's disease in children: an international collaborative study of 86 cases","volume":"132","author":"Kon\u00e9-Paut","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaut.2009.02.011_bib28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kem199","article-title":"Efficacy and safety of interferon-\u03b1 in the treatment of corticodependent uveitis of paediatric Behcet's disease","volume":"46","author":"Guillaume-Czitrom","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1346-8138.2003.tb00423.x","article-title":"The clinical course of Behcet's disease in pregnancy: a retrospective analysis and review of the literature","volume":"30","author":"Uzun","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib30","doi-asserted-by":"crossref","unstructured":"Bang D, Chun YS, Haam IB, Lee ES, Lee S, et\u00a0al. The influence of pregnancy on Behcet's disease. Yonsei Med J 1997;38:437\u2013443.","DOI":"10.3349\/ymj.1997.38.6.437"},{"key":"10.1016\/j.jaut.2009.02.011_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-006-0281-6","article-title":"Immunopathogenesis of Beh\u00e7et's disease with special emphasize to the possible role of antigen presenting cells","volume":"27","author":"Pay","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2009.02.011_bib32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-007-0367-9","article-title":"Pro-inflammatory cellular immune response in Beh\u00e7et's disease","volume":"27","author":"Kulaber","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2009.02.011_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.10815","article-title":"Mapping the HLA association in Beh\u00e7et's disease a role for tumor necrosis factor polymorphisms?","volume":"48","author":"Ahmad","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Beh\u00e7et's disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.0906-6705.2005.00253.x","article-title":"Specific interleukin-1 gene polymorphisms in Turkish patients with Beh\u00e7et's disease","volume":"14","author":"Coskun","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/keg232R","article-title":"Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Beh\u00e7et's disease","volume":"42","author":"Karasneh","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib37","first-page":"1283","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in Beh\u00e7et's disease","volume":"28","author":"Boiardi","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-2370.2000.00202.x","article-title":"Intercellular adhesion molecule-1 gene polymorphism in Beh\u00e7et's disease","volume":"27","author":"Verity","year":"2000","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaut.2009.02.011_bib39","first-page":"535","article-title":"Endothelial nitric oxide synthase gene polymorphisms in Beh\u00e7et's disease","volume":"29","author":"Salvarani","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/03009740801998788","article-title":"Molecular analysis of MEFV gene mutations among Palestinian patients with Beh\u00e7et's disease","volume":"37","author":"Ayesh","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009740600759639","article-title":"Common FMF alleles may predispose to development of Beh\u00e7et's disease with increased risk for venous thrombosis","volume":"36","author":"Rabinovich","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/03009740510017931","article-title":"MEFV gene is a probable susceptibility gene for Beh\u00e7et's disease","volume":"34","author":"Imirzalioglu","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh\u00e7et's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jaut.2009.02.011_bib44","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/ard.60.11.996","article-title":"Beh\u00e7et's disease: infectious aetiology, new autoantigens, and HLA-B51","volume":"60","author":"Direskeneli","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1067\/mjd.2001.117728","article-title":"HSP 60 expression in mucocutaneous lesions of Beh\u00e7et's disease","volume":"45","author":"Ergun","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00296-005-0029-8","article-title":"Serum interleukin-18 levels in patients with Beh\u00e7et's disease. Is its expression associated with disease activity or clinical presentations?","volume":"26","author":"Musabak","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2009.02.011_bib47","first-page":"655","article-title":"Levels of IL-15 in serum and cerebrospinal fluid of patients with Beh\u00e7et's disease","volume":"64","author":"Hamzaoui","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Beh\u00e7et\u2019s disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaut.2009.02.011_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1067\/mlc.2003.1","article-title":"Expansion of \u03b3\u03b4 T-cells in Behcet's disease: role of disease activity and microbial flora in oral ulcers","volume":"141","author":"Bank","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(02)00208-4","article-title":"V\u03b39V\u03b42 T cells recovered from eyes of patients with Behcet's disease recognize non-peptide prenyl pyrophosphate antigens","volume":"130","author":"Verjans","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaut.2009.02.011_bib51","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(96)90868-5","article-title":"Role of \u03b3\u03b4 T cells in pathogenesis and diagnosis of Beh\u00e7et's disease","volume":"347","author":"Hasan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2009.02.011_bib52","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","article-title":"Beh\u00e7et's disease \u2013 from Hippocrates to the third millennium","volume":"87","author":"Verity","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib54","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","article-title":"Immunology and functional genomics of Beh\u00e7et's disease","volume":"60","author":"Zierhut","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaut.2009.02.011_bib55","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3349\/ymj.2007.48.4.573","article-title":"Mucocutaneous lesions of Beh\u00e7et's disease","volume":"48","author":"Alpsoy","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaut.2009.02.011_bib56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000074113","article-title":"Review of the chronology of clinical manifestations in 60 patients with Beh\u00e7et's disease","volume":"2007","author":"Alpsoy","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib57","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1346-8138.1995.tb03947.x","article-title":"Prognosis and clinical relevance of recurrent oral ulceration in Behcet's disease","volume":"22","author":"Bang","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib58","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/31.11.767","article-title":"Clinical differentiation of oral ulceration in Beh\u00e7et's","volume":"31","author":"Main","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib59","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","article-title":"Ocular features of Beh\u00e7et's disease: an international collaborative study","volume":"91","author":"Nobuyoshi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib60","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3129\/i08-080","article-title":"Beh\u00e7et's disease: comparing 3 decades of treatment response at the National Eye Institute","volume":"43","author":"Kump","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0021-5155(99)00029-5","article-title":"Epidemiological features and visual prognosis of Beh\u00e7et's disease","volume":"43","author":"Ando","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Beh\u00e7et's disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaut.2009.02.011_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00061198-200412000-00002","article-title":"Incidence of secondary glaucoma in Beh\u00e7et disease","volume":"13","author":"Elgin","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jaut.2009.02.011_bib64","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0190-9622(95)91333-5","article-title":"Mucocutaneous criteria for the diagnosis of Beh\u00e7et's disease: an analysis of clinicopathologic data","volume":"32","author":"Jorizzo","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib65","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1468-3083.2003.00625.x","article-title":"Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behcet's disease","volume":"17","author":"Alpsoy","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaut.2009.02.011_bib66","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2009.02.011_bib67","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jnnp.2006.093971","article-title":"Neurological symptoms of Adamantiades-Beh\u00e7et's syndrome","volume":"77","author":"Pearce","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaut.2009.02.011_bib68","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0035-3787(06)75121-9","article-title":"Neurological involvement in Behcet's disease. 154 cases from a cohort of 925 patients and review of the literature","volume":"162","author":"Benamour","year":"2006","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jaut.2009.02.011_bib69","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","article-title":"Clinical manifestations of Behcet's disease: an analysis of 2147 patients","volume":"38","author":"G\u00fcrler","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaut.2009.02.011_bib70","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1191\/0961203305lu2208oa","article-title":"Beh\u00e7et's disease and cardiovascular involvement","volume":"14","author":"Atzeni","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2009.02.011_bib71","first-page":"35","article-title":"Basilar artery aneurysm associated with Beh\u00e7et's disease: a case report","volume":"18","author":"Ger\u00e7ek Aktas","year":"2008","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.jaut.2009.02.011_bib72","doi-asserted-by":"crossref","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et\u00a0al. The long-term mortality and morbidity of Beh\u00e7et syndrome A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60\u201376.","DOI":"10.1097\/00005792-200301000-00006"},{"key":"10.1016\/j.jaut.2009.02.011_bib73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.gcb.2007.12.022","article-title":"Budd\u2013Chiari syndrome associated with Beh\u00e7et's disease","volume":"32","author":"Ghorbel","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jaut.2009.02.011_bib74","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","article-title":"Pulmonary artery aneurisms in Beh\u00e7et's syndrome","volume":"117","author":"Hamuryudan","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib75","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/rheumatology\/33.1.48","article-title":"Pulmonary arterial aneurysms in Beh\u00e7et's syndrome: a report of 24 cases","volume":"33","author":"Hamuryudan","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1536\/jhj.43.389","article-title":"Cardiovascular involvement in Behcet's disease","volume":"43","author":"Gurgun","year":"2002","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jaut.2009.02.011_bib77","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.55.3.208","article-title":"Gastrointestinal involvement in Behcet's syndrome: a controlled study","volume":"55","author":"Yurdakul","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib78","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/gast.2001.22556","article-title":"Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh\u00e7et's disease: a case report","volume":"120","author":"Hassard","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2009.02.011_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.revmed.2007.09.031","article-title":"Les manifestations articulaires de la maladie de Beh\u00e7et. \u00c0 propos de 79 cas","volume":"29","author":"Badi","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jaut.2009.02.011_bib80","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/ard.52.8.619","article-title":"Effect of surgical clearing of the skin on the pathergy phenomenon in Beh\u00e7et's syndrome","volume":"52","author":"Fresco","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/ard.28.2.95","article-title":"Beh\u00e7et's syndrome with arthritis","volume":"28","author":"Mason","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib82","first-page":"59","article-title":"Recent research into Beh\u00e7et's disease in Japan","volume":"10","author":"Mizushima","year":"1988","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.jaut.2009.02.011_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10238-004-0033-4","article-title":"Beh\u00e7et disease","volume":"3","author":"Suzuki","year":"2004","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib84","first-page":"2371","article-title":"Crit\u00e8res proposes pour la diagnostic maladie Beh\u00e7et et notes th\u00e9rapeutiques","volume":"36","author":"O'Duffy","year":"1974","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jaut.2009.02.011_bib86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0950-3579(05)80196-7","article-title":"Beh\u00e7et's disease","volume":"9","author":"Rigby","year":"1995","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib87","first-page":"177","article-title":"Our diagnostic criteria for Beh\u00e7et's disease\u2014an overview","volume":"103","author":"Dilsen","year":"1986","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.jaut.2009.02.011_bib88","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2009.02.011_bib89","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00063030-200115010-00003","article-title":"Potential new therapeutic options in Behcet's syndrome","volume":"15","author":"Russell","year":"2001","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaut.2009.02.011_bib90","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/00003495-200767140-00004","article-title":"Standard and novel therapeutic approaches to Beh\u00e7et's disease","volume":"67","author":"Gul","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2009.02.011_bib91","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0927-3948(200006)821-0FT085","article-title":"Drug therapy in Behcet's disease","volume":"8","author":"Okada","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaut.2009.02.011_bib94","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","article-title":"A double-blind trial of depot corticosteroids in Beh\u00e7et's syndrome","volume":"45","author":"Mat","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib95","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib97","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Beh\u00e7et's disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaut.2009.02.011_bib98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","article-title":"Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Beh\u00e7et's disease","volume":"159","author":"Hirohata","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jaut.2009.02.011_bib99","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007691-199810000-00002","article-title":"The monitoring of immunosuppressive drugs: a pharmacodynamic approach","volume":"20","author":"Yatscoff","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jaut.2009.02.011_bib100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib101","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Beh\u00e7et's syndrome effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0753-3322(01)00154-8","article-title":"Thalidomide in Beh\u00e7et's disease","volume":"56","author":"Shek","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaut.2009.02.011_bib104","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's Syndrome","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib107","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Beh\u00e7et's disease: a double-blind, placebo-controlled, crossover study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib108","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","article-title":"Successful treatment of Behcet's disease with pentoxifylline","volume":"124","author":"Yasui","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib109","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/rheumatology\/keh311","article-title":"Influence of human recombinant interferon-\u03b12a (rhIFN- \u03b12a) on altered lymphocyte subpopulations and monocytes in Beh\u00e7et's disease","volume":"43","author":"Treusch","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","article-title":"New approaches in the treatment of Adamantiades-Behcet's disease","volume":"18","author":"Pipitone","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Beh\u00e7et's disease with sight threatening posterior uveitis","volume":"87","author":"K\u00f6tter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Beh\u00e7et disease a randomized placebo-controlled and double-blind Study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00041327-200106000-00011","article-title":"Interferon alfa-2a treatment of neuro-Beh\u00e7et disease","volume":"21","author":"Nichols","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib114","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2169\/internalmedicine.39.667","article-title":"Beneficial effects of interferon-alpha in a case with Behcet disease","volume":"39","author":"Aoki","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","article-title":"Treatment of Adamantiades-Beh\u00e7et's disease with systemic interferon alfa","volume":"134","author":"Zouboulis","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib116","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","article-title":"Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Beh\u00e7et's disease","volume":"8","author":"Wechsler","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaut.2009.02.011_bib117","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2796.1998.00159.x","article-title":"Efficacy and safety of systemic recombinant interferon-alpha in Behcet's disease","volume":"243","author":"Georgiou","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib118","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/ard.62.5.492","article-title":"Effects of interferon \u03b1 treatment on the clinical course of refractory Beh\u00e7et's disease: an open study","volume":"62","author":"\u00c7alg\u00fcneri","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib119","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon \u03b1 in Beh\u00e7et disease: review of the literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","article-title":"Differential efficacy of human recombinant interferon-\u03b12a on ocular and extraocular manifestations of Beh\u00e7et disease: results of an open 4-center trial","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib121","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib122","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bjo.87.4.381","article-title":"Beh\u00e7et's syndrome","volume":"87","author":"Stanford","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaut.2009.02.011_bib123","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncprheum0825","article-title":"Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases","volume":"4","author":"Langford","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib124","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.61.suppl_2.ii51","article-title":"Beh\u00e7et's disease: a new target for anti-tumour necrosis factor treatment","volume":"61","author":"Sfikakis","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib126","doi-asserted-by":"crossref","unstructured":"Triolo G, Vadal\u00e0 A, Accardo-Palumbo A, Ferrante A, Ciccia F, Giardina E, et\u00a0al. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Beh\u00e7et's disease. Ann Rheum Dis 2002;61:560\u20131.","DOI":"10.1136\/ard.61.6.560"},{"key":"10.1016\/j.jaut.2009.02.011_bib127","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study","volume":"46","author":"Niccoli","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2009.02.011_bib129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease","volume":"140","author":"Sfikakis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2474-4-19","article-title":"Remission of Beh\u00e7et's disease with anti-tumour necrosis factor monoclonal antibody therapy: a case report","volume":"4","author":"Gulli","year":"2003","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jaut.2009.02.011_bib131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/40.4.473","article-title":"Treatment of recalcitrant orogenital ulcers of Beh\u00e7et's syndrome with infliximab","volume":"40","author":"Robertson","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib132","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.11204","article-title":"Treatment with infliximab for a child with Beh\u00e7et's disease","volume":"49","author":"Saulsbury","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib133","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.61.3.283-a","article-title":"Remission of Beh\u00e7et's syndrome with TNFa blocking treatment","volume":"61","author":"Rozenbaum","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib134","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2003.010975","article-title":"Successful treatment of genital ulcers with infliximab in Beh\u00e7et's disease","volume":"63","author":"Haugeberg","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.49.5.725","article-title":"Treatment of intestinal Beh\u00e7et's syndrome with chimeric tumour necrosis factor \u03b1 antibody","volume":"49","author":"Travis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2009.02.011_bib136","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","article-title":"Infliximab for the treatment of Neuro-Beh\u00e7et's disease: a case series and review of the literature","volume":"59","author":"Pipitone","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2009.02.011_bib137","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/jnnp.2004.055434","article-title":"Efficacy of TNF \u03b1 blockade in cyclophosphamide resistant neuro-Beh\u00e7et disease","volume":"76","author":"Ribi","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaut.2009.02.011_bib138","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/ard.62.3.280","article-title":"Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Beh\u00e7et's syndrome","volume":"62","author":"Licata","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib139","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/ard.2005.045195","article-title":"Beh\u00e7et's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment","volume":"65","author":"Baki","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib140","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib141","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/kem103","article-title":"Infliximab in the treatment of hepatic vein thrombosis (Budd\u2013Chiari syndrome) in 3 patients with Beh\u00e7et's syndrome","volume":"46","author":"Seyahi","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib142","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","article-title":"Anti-TNF therapy in the management of Beh\u00e7et's disease \u2013 review and basis for recommendations","volume":"46","author":"Sfikakis","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib143","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10067-008-0857-5","article-title":"Efficacy of etanercept in the treatment of a patient with Beh\u00e7et's disease","volume":"27","author":"Curigliano","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib144","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double-blind, placebo\u2013controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2009.02.011_bib145","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/41.10.1213-c","article-title":"Beh\u00e7et's syndrome: response to infliximab after failure of etanercept","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2009.02.011_bib146","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","article-title":"Adalimumab for sight-threatening uveitis in Behcet's disease","volume":"21","author":"Mushtaq","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.jaut.2009.02.011_bib147","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","article-title":"Adalimumab: a new modality for Beh\u00e7et's disease?","volume":"66","author":"van Laar","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib148","doi-asserted-by":"crossref","first-page":"iii22","DOI":"10.1136\/ard.2008.100834","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases","volume":"67","author":"Furst","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2009.02.011_bib149","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-149-4-200808190-00018","article-title":"Resistant Beh\u00e7et disease responsive to Anakinra","volume":"149","author":"Botsios","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2009.02.011_bib150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/immu.200390025","article-title":"Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit","volume":"33","author":"Phipps","year":"2003","journal-title":"Eur J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2009.02.011_bib151","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","article-title":"Oral tolerization with peptide 336\u2013351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet\u00b4s disease","volume":"137","author":"Stanford","year":"2004","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841109000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:00:26Z","timestamp":1760256026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841109000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":145,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0896841109000262"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2009.02.011","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beh\u00e7et's disease \u2013 a contemporary review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2009.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}